Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4216098 | Revue des Maladies Respiratoires Actualités | 2011 | 5 Pages |
Abstract
Surgical resection remains the only curative treatment of lung cancer. Until then, there was no official reference for assessing the quality of the act. Since 2008, the publication of evidence-based recommendations, the SFCTCV, has identified a set of good practice. These recommendations relate to the act itself, ie: the incision, the type of parenchymal resection, lymph node expertise, but also the infrastructure which the act takes place and finally the activity surgeon. Quality criteria have been defined. They relate to the morbidity and the mortality after surgery, quality of resection, number of lymph nodes dissection and survival in the long term. The participation of every thoracic surgeon to a national database (EPITHOR) allows to define thresholds for each criterion. Thus, each surgeon has the opportunity to compare his work to national data updated annually.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
L. Brouchet,